Literature DB >> 35554919

Strengthening Biorisk Management in Research Laboratories with Security-Sensitive Biological Agents Like SARS-CoV-2.

Sabai Phyu1,2, Tessy Joseph3, Margarida Goulart4.   

Abstract

In this chapter, we discuss potential incidents associated with SARS-CoV-2 experimental work in high containment research laboratories. The risk landscape in high containment laboratories is changing due to the strong innovation drive of the life sciences research. Thus, the WHO has recommended life sciences organizations to incorporate good research practices and ethical principles into a risk-based approach of the biorisk management (BRM). Currently, BRM systems in high containment laboratories are predominantly steered by operational personnel and laboratory professional. It is well known that without having a systematic approach and leadership support from the organization, the BRM system in the high containment laboratory will not be sustainable. Even though the roles of organizations and their leadership in establishing the BRM system are spelt out in many international standards, guidance documents and national legislations, operational aspects of these roles are rarely discussed.It is therefore important for everyone to understand about their roles in organizational processes (communication, decision, and performance evaluation) involved in implementation of BRM related operational activities. In this chapter, discussion is based on operational activities of four main organizational behaviors that are considered to have strengthened BRM systems in high containment laboratories: (1) displaying a visible commitment and support to the BRM system from different levels of management, (2) developing a competent and responsible workforce with BRM technical skills and problem identification/solving skills, (3) integrating learning and improvement principles into the BRM system, and (4) enhancing the continuous motivation of laboratory personnel to avoid complacency. The categorization of these organizational behaviors is based on the International Atomic Energy Agency's principles and guidance for strengthening the safety and security culture in nuclear facilities. Furthermore, we encourage the laboratory management to identify gaps in processes and activities related to those organizational behaviors so that one could rapidly address biosafety and biosecurity vulnerabilities in high containment laboratories.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Biorisk management; Biosafety; Biosecurity; Organizational behaviors; Security-sensitive or high-risk biological agents

Mesh:

Substances:

Year:  2022        PMID: 35554919     DOI: 10.1007/978-1-0716-2111-0_23

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Human error: models and management.

Authors:  J Reason
Journal:  BMJ       Date:  2000-03-18

2.  Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template.

Authors:  Jeronimo Cello; Aniko V Paul; Eckard Wimmer
Journal:  Science       Date:  2002-07-11       Impact factor: 47.728

3.  Infectious diseases. Mounting lab accidents raise SARS fears.

Authors:  Dennis Normile
Journal:  Science       Date:  2004-04-30       Impact factor: 47.728

4.  Biosafety lapses prompt US CDC to shut labs and launch review.

Authors:  Michael McCarthy
Journal:  BMJ       Date:  2014-07-14

5.  Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.

Authors:  Ariella M Rosengard; Yu Liu; Zhiping Nie; Robert Jimenez
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

6.  Characterization of the reconstructed 1918 Spanish influenza pandemic virus.

Authors:  Terrence M Tumpey; Christopher F Basler; Patricia V Aguilar; Hui Zeng; Alicia Solórzano; David E Swayne; Nancy J Cox; Jacqueline M Katz; Jeffery K Taubenberger; Peter Palese; Adolfo García-Sastre
Journal:  Science       Date:  2005-10-07       Impact factor: 47.728

7.  Impact of weather conditions on incidence and mortality of COVID-19 pandemic in Africa.

Authors:  S A Meo; A A Abukhalaf; A A Alomar; T W Aljudi; H M Bajri; W Sami; J Akram; S J Akram; W Hajjar
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-09       Impact factor: 3.507

8.  Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light.

Authors:  Izabela Ragan; Lindsay Hartson; Heather Pidcoke; Richard Bowen; Raymond Goodrich
Journal:  PLoS One       Date:  2020-05-29       Impact factor: 3.240

Review 9.  Biopreparedness in the Age of Genetically Engineered Pathogens and Open Access Science: An Urgent Need for a Paradigm Shift.

Authors:  C Raina MacIntyre
Journal:  Mil Med       Date:  2015-09       Impact factor: 1.437

Review 10.  Zoonotic and reverse zoonotic events of SARS-CoV-2 and their impact on global health.

Authors:  Khalid Munir; Shoaib Ashraf; Isra Munir; Hamna Khalid; Mohammad Akram Muneer; Noreen Mukhtar; Shahid Amin; Sohaib Ashraf; Muhammad Ahmad Imran; Umer Chaudhry; Muhammad Usman Zaheer; Maria Arshad; Rukhsana Munir; Ali Ahmad; Xin Zhao
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.